MannKind Corporation to Present at Imperial Capital 2012 Healthcare Investor Forum

VALENCIA, Calif.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the Imperial Capital 2012 Healthcare Investor Forum on Tuesday, April 17, 2012 at 9:00 am Eastern Time at the New York Palace in New York.

MORE ON THIS TOPIC